Publikationen 2015

  • Kröz M, Reif M, Zerm R, Winter K, Schad F, Gutenbrunner C, Girke M, Bartsch C: Do we have predictors of therapy responsiveness for a multimodal therapy concept and aerobic training in breast cancer survivors with chronic cancer-related fatigue? Eur J Cancer Care (Engl). 2015 24(5):707-17. doi: 10.1111/ecc.12278. Epub 2015 Jan 19. PMID: 25602030
  • Baars EW, Ponstein A, Kok ET, Heybroek R, Van der Veen W, Kröz M, de Bruin A: Validation of the Dutch Version of the Autonomic regulation (State-aR) Questionnaire in a Group of patients and a group of Healthy Persons. Eur J Integr Med 2015, 7(S1):52.
  • Kröz M, Reif M, Pranga D, Berger B, Nikolaou A, Zerm R, Brinkhaus B, Heckmann C, Girke M, Bartsch C, Gutenbrunner C, Lötzke D, Büssing A: Effectiveness of a Multimodal and Combined Therapy in Breast Cancer Survivors with Cancer-related Fatigue on Self-Regulation and Internal Coherence. Eur J Integr Med 2015, 7(S1):12.
  • Kröz M, Reif M, Glinz A, Berger B, Nikolaou A, Zerm R, Brinkhaus B, Girke M, Büssing A, Gutenbrunner C: Multimodal and combined multimodal-aerobic therapy in breast cancer survivors with cancer-related fatigue. J Clin Oncol ASCO Annual Meeting 2015, 33(Suppl. e20717).
  • Lötzke D, Rodrigues Recchia D, Kröz M, Reif M, Gutenbrunner C, Zerm R, Nikolaou A, Berger B, Büssing A: The influence of a multimodal therapy concept on health-related quality of life in breast cancer survivors with cancer-related fatigue in comparison to a standard aerobic therapy. Eur J Integr Med 2015, 7(S1):14.
  • Steele M, Axtner J, Happe A, Kröz M, Matthes H, Schad F: Safety of combined therapy with Helixor mistletoe preparations and targeted therapies in cancer patients. Eur J Integr Med 2015, 7(S1):51.
  • Zerm R, Jecht M, Pranga D, Girke M, Kröz M: Autonomic regulation in type 2 diabetes with and without concomitant obstructive sleep apnea syndrome. Eur J Integr Med 2015, 7(S1):52.
  • Kröz M, Büssing A, Reif M, Pranga D, Schad F, Zerm R, Matthes H, Girke M: Is Mistletoe Therapy indicated to reduce Cancer-related Fatigue and Insomnia in Cancer Patients? Phytomedicine 2015, 22(Supplement 1):29.
  • Steele M, Axtner J, Kröz M, Matthes H, Schad F: Adverse drug reactions to therapy with European Mistletoe Viscum album L. Phytomedicine 2015, 22(Supplement 1):17.
  • Glinz A, Zerm R, Heckmann C, Reif M, Pranga D, ten Brink F, Berger B, Gutenbrunner C, Kröz M: Ein multimodales und ein kombiniertes multimodal-aerobes Therapiekonzept verbessern im Vergleich zu einer rein aeroben Therapie die Schlafqualität von Brustkrebs-Patientinnen mit Cancer-related Fatigue. Somnologie 2015, 19(S2):97.
  • Megan L. Steele, Jan Axtner, Antje Happe, Matthias Kröz, Harald Matthes, and Friedemann Schad. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology. Integr Cancer Ther. 2015 Mar;14(2):140-8. doi: 10.1177/1534735414563977. Epub 2014 Dec 30.